• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Upcoming dvm360 Conferences
Resources
CBD in Pets
CE Requirements by State
Contests
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
Veterinary Heroes
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

UPDATE: FDA Extends Deadline for Input on Evaluation of New Heartworm Preventives

August 17, 2018
Kerry Lengyel

The FDA is calling on the public to help determine how animal drug sponsors can better demonstrate the effectiveness of new canine heartworm preventives.

UPDATE (August 17) — The FDA announced today that it is extending the deadline for input on how heartworm preventive studies should be evaluated. The extension is a direct result of requests for additional time to submit comments.

Originally scheduled to close on August 22, the comment period will remain open until November 20.

If you have input on how the process could be changed, send your comments through the FDA regulations electronic filing system.

(May 23) — Despite the number of heartworm preventives that have been widely available for decades, the incidence of infection continues to rise. The most recent estimates from the American Heartworm Society indicate that more than 1 million dogs were heartworm-positive in 2016, and heartworm infections are expected to be above average nationwide this year, leaving many of the country’s pets at risk. Although experts point to poor compliance as a leading cause of rising incidence rates, these statistics mark the need for better, more effective preventive medications.

Fortunately, the Food and Drug Administration (FDA) announced today that its Center for Veterinary Medicine (CVM) is stepping up to the challenge.

RELATED:

Advertisement
  • Feline Heartworm Preventive Receives FDA Approval
  • ACVIM 2017: An Alternative Treatment for Heartworm Disease

“There are gaps in knowledge that have prevented the FDA CVM from fully evaluating which alternative approaches are suitable for meeting the standards of effectiveness,” the administration wrote in its announcement.

To bridge these gaps, investigators are seeking input on how heartworm preventive studies should be evaluated.

Currently, canine heartworm medications are shown to be effective after sponsors conduct 2 laboratory dose confirmation studies and 1 multisite field safety and effectiveness study under the principles of Good Clinical Practice. But the FDA CVM believes this process has various limitations due to the evolving susceptibility of Dirofilaria immitis larvae to heartworm preventives containing macrocyclic lactones.

Globally, heartworm preventives are still largely effective, but veterinarians should be aware that resistant biotypes of D immitis have been confirmed.

To help produce more effective preventive medications, the FDA CVM is requesting public comment on alternative approaches for evaluating new heartworm preventives or developing study designs. Specifically, the center is looking for input on the following topics:

  • Defining an appropriate population-level effectiveness endpoint
  • Assessing exposure to infective D immitis larvae in a clinical setting
  • Outcome assessment for effectiveness

As a veterinarian, you play a vital role in educating clients and engaging in conversations about proper heartworm prevention, and now you can help with the future of preventive medicine for this ever-growing issue.

If you have input on how the process could be changed, send your comments through the FDA regulations electronic filing system by August 22.

Related Content:

Parasitology
AHS urges veterinarians to submit data for 2022 Heartworm Incidence Map
AHS urges veterinarians to submit data for 2022 Heartworm Incidence Map
Top dvm360 podcasts of 2022: #3
Top dvm360 podcasts of 2022: #3
Common errors in parasite fecal diagnostics
Common errors in parasite fecal diagnostics

Advertisement

Latest News

The four-letter word to why you're burning out and feeling unproductive

Merck Manuals recognizes importance of One Health concept

Topical therapy and immunotherapy can save time and frustration with dermatology cases

Texas Tech appoints new faculty member with passion for animal agriculture

View More Latest News
Advertisement